Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Personalis, Inc.(PSNL) | 14,044,943 | 14,044,943 | 0 | $49.30M | $92.13M | 42.73% | +$42.84M |
| Moderna, Inc.(MRNA) | 2,308,190 | 2,308,190 | 0 | $65.44M | $63.68M | 29.54% | -$1.75M |
| Kymera Therapeutics, Inc.(KYMR) | 772,165 | 772,165 | 0 | $21.13M | $33.70M | 15.63% | +$12.56M |
| Entrada Therapeutics, Inc.(TRDA) | 1,739,768 | 1,739,768 | 0 | $15.73M | $11.69M | 5.42% | -$4.04M |
| Alector Inc | 3,545,719 | 3,545,719 | 0 | $4.36M | $4.96M | 2.30% | +$602.8K |
| Evaxion Biotech A/sADS | 1,214,126 | 1,214,126 | 0 | $2.25M | $2.97M | 1.38% | +$728.5K |
| Sutro Biopharma, Inc.(STRO) | 2,723,509 | 2,723,509 | 0 | $1.77M | $1.94M | 0.90% | +$172.4K |
| Lava Therapeutics NvSHS | 1,149,345 | 1,149,345 | 0 | $1.46M | $1.52M | 0.70% | +$57.5K |
| Viridian Therapeutics, Inc.(VRDN) | 93,414 | 93,414 | 0 | $1.26M | $1.31M | 0.61% | +$46.7K |
| Xilio Therapeutics, Inc.(XLO) | 1,483,758 | 1,483,758 | 0 | $1.07M | $1.01M | 0.47% | -$66.0K |
| Carisma Therapeutics Inc | 1,473,240 | 1,473,240 | 0 | $456.7K | $576.9K | 0.27% | +$120.2K |
| Neuphoria Therapeutics Inc | 10,027 | 10,027 | 0 | $57.8K | $71.2K | 0.03% | +$13.4K |
| TuHURA Biosciences, Inc.(HURA) | 0 | 13,950 | +13,950 | $0 | $31.1K | 0.01% | +$31.1K |